课题基金 / 基金详情

A WORLD WIDE, PHASE I, DOSE ESCALATING STUDY OF THE SAFETY, TOLERABILITY, AND

A WORLD WIDE, PHASE I, DOSE ESCALATING STUDY OF THE SAFETY, TOLERABILITY, AND
一项关于安全性、耐受性和安全性的全球第一阶段剂量递增研究
批准号:
7605560
负责人:
PETER Edwin WRIGHT
金额:
$0.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-09-16

项目摘要

项目成果

PETER Edwin WRIGHT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Specific aims: to assess the safety of a 3-dose regimen of MRKAd5 HIV-1 gag vaccine at 1x10^9 and 1x10^10 viral particles/dose.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural characterization of large eukaryotic proteins containing both folded and disordered domains
  • 批准号:
    10552345
  • 项目类别:
  • 资助金额:
    $45.25万
  • 财政年份:
    2023
  • 负责人:
    PETER Edwin WRIGHT
  • 依托单位:
Molecular mechanisms of transthyretin amyloidosis
  • 批准号:
    10115719
  • 项目类别:
  • 资助金额:
    $45.64万
  • 财政年份:
    2020
  • 负责人:
    PETER Edwin WRIGHT
  • 依托单位:
Molecular mechanisms of transthyretin amyloidosis
  • 批准号:
    10599188
  • 项目类别:
  • 资助金额:
    $46.54万
  • 财政年份:
    2020
  • 负责人:
    PETER Edwin WRIGHT
  • 依托单位:
Molecular mechanisms of transthyretin amyloidosis
  • 批准号:
    10372930
  • 项目类别:
  • 资助金额:
    $45.64万
  • 财政年份:
    2020
  • 负责人:
    PETER Edwin WRIGHT
  • 依托单位:
海外基金